Categories: NewsVaccine

Here for Good: Merck’s Steadfast Commitment to Health Equity

How one employee’s upbringing and career journey have motivated her to fight inequities around the world

NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she’s done across industries.

As a young girl growing up in central London, Agrawal saw firsthand how inequities even within her own extended family could drastically impact health outcomes.

“I watched my father’s side of the family – who lived in London – live with diabetes, but I watched my mother’s side of the family – who lived in North India – die of diabetes,” Agrawal said. “It took me a while to figure out that it was my father’s family’s access to the National Health Service that made the difference.”

That early insight propelled Agrawal into a career as an obstetrician and gynecologist before moving into public health. She first joined Merck to help launch Merck for Mothers, a global initiative to help create a world where no woman has to die while giving life. From there, she went on to a variety of roles – from lead of the company’s vaccines and contraceptives business in the U.K. to managing director of South Africa and Sub-Saharan Africa to global head of HPV vaccines. She currently serves as vice president of health equity and partnerships.

Agrawal’s work – and the passion that fuels it – continues, and she has no plans to stop.

“My purpose in life is to advance health equity. I want to be able to say that I did all I could to ensure more people could both survive and thrive because they had easier access to health.”

View original content here.

https://www.3blmedia.com/sites/default/files/2024-06/Here-for-Good-%20A-steadfast-commitment-to-health-equity_Merck_061224.mp4

View additional multimedia and more ESG storytelling from Merck & Co., Inc. on 3blmedia.com.

Contact Info:
Spokesperson: Merck & Co., Inc.
Website: https://www.3blmedia.com/profiles/merck-co-inc
Email: info@3blmedia.com

SOURCE: Merck & Co., Inc.

View the original press release on accesswire.com

View the original press release on accesswire.com

Staff

Recent Posts

Analysis Finds Misinformation About Interchangeable Biosimilars Undermining US Health Policy, Physician Confidence, and Patient Health

WASHINGTON, DC / ACCESSWIRE / July 16, 2024 / The Alliance for Safe Biologic Medicines…

8 hours ago

Vituity Cares Foundation Joins Forces With the Magic Johnson Foundation and Justin Carr Wants World Peace Foundation for the 2nd Annual Back-to-School Community Event in LA

Comprehensive Back-to-School Event on Saturday, July 20, 2024, Will Feature Life-Saving Cardiac Screenings Alongside Free…

8 hours ago

Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks

CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative…

11 hours ago

AI Tool Successfully Responds to Patient Questions in Electronic Health Record

NEW YORK, July 16, 2024 /PRNewswire/ -- As part of a nationwide trend, many more…

11 hours ago